A photo of Parinda Mehta.

Member, Division of Bone Marrow Transplantation and Immune Deficiency

Professor, UC Department of Pediatrics

513-636-4913

513-803-1969

Board Certified

About Me

Academic Affiliation

Professor, UC Department of Pediatrics

Clinical Divisions

Cancer and Blood Diseases, Bone Marrow Transplantation BMT, Fanconi Anemia, Leukemia

My Locations

My Education

BA: Graduated from Parle College, Mumbai, India, 1988.

MD: G.S. Medical College and K.E.M Hospital, Mumbai, India, 1993.

Residency: Upstate Medical University (UMU) - State University of New York (SUNY), Syracuse, NY, 2002.

Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2005.

Certification: Board Certification, Pediatrics, 2002; Board Certification, Pediatric Hematology Oncology, License, State of Ohio.

My Publications

Selected Publication

Busulfan Pharmacokinetics and Precision Dosing: Are Patients with Fanconi Anemia Different?. Mehta, PA; Emoto, C; Fukuda, T; Seyboth, B; Teusink-Cross, A; Davies, SM; Wilhelm, J; Fuller, K; Vinks, AA; Boulad, F. Biology of Blood and Marrow Transplantation. 2019; 25:2416-2421.

Unique Challenges of Hematopoietic Cell Transplantation in Adolescent and Young Adults with Hematologic Malignancies. Mehta, PA; Rotz, SJ; Majhail, NS. Biology of Blood and Marrow Transplantation. 2018; 24:e11-e19.

Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Dvorak, CC; Satwani, P; Stieglitz, E; Cairo, MS; Dang, H; Pei, Q; Gao, Y; Wall, D; Mazor, T; Olshen, AB; et al. Pediatric Blood and Cancer. 2018; 65.

Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study. Chandra, S; Fukuda, T; Mizuno, K; Davies, SM; Teusink-Cross, A; Tarin, R; Marsh, RA; Vinks, AA; Mehta, PA. Journal of Antimicrobial Chemotherapy. 2018; 73:1651-1658.

A prospective pilot study of a novel alemtuzumab target concentration intervention strategy. Arnold, DE; Emoto, C; Fukuda, T; Dong, M; Vinks, AA; Lane, A; McIntosh, K; Neumeier, L; Lankester, AC; Achini, F; et al. Bone Marrow Transplantation. 2021.

Modern Lung Magnetic Resonance Imaging to Screen for Pulmonary Complications in Patients with Dyskeratosis Congenita. Walkup, LL; Myers, KC; Willmering, MM; Mehta, PA; Nelson, AS; Fleck, RJ; Woods, JC; Davies, SM; Towe, CT. American Journal of Respiratory and Critical Care Medicine. 2021.

Daratumumab for the management of autoimmune cytopenias in children and young adults: a case series. Khandelwal, P; Teusink-Cross, A; Kumar, AR; Bleesing, JJ; Mehta, PA; Jordan, MB; Chandra, S; Davies, SM; Marsh, RA. British Journal of Haematology. 2021; 194:e84-e89.

α4β7 Integrin expression and blockade in pediatric and young adult gastrointestinal graft-versus-host disease. Ibrahimova, A; Davies, SM; Lane, A; Jordan, MB; Lake, K; Litts, B; Chaturvedi, V; Owsley, E; Myers, KC; Nelson, AS; et al. Pediatric Blood and Cancer. 2021; 68.

Model-informed precision dosing for alemtuzumab in paediatric and young adult patients undergoing allogeneic haematopoietic cell transplantation. Dong, M; Emoto, C; Fukuda, T; Arnold, DE; Mehta, PA; Marsh, RA; Vinks, AA. British Journal of Clinical Pharmacology. 2021.

Test-dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non-malignant disorders. Chandra, S; Mizuno, K; Zhao, J; Davies, SM; Marsh, RA; Fukuda, T; Setchell, KD R; Vinks, AA; Mehta, PA. British Journal of Clinical Pharmacology. 2021.